Síntese e caracterização de novos complexos de prata(I) com sulfadiazina e trifenilfosfina
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and
remains one of the major global public health problems. As a mycobacterium, its cell
wall contains both hydrophilic and lipophilic layers, which confer low drug permeability
and reduce the effectiveness of conventional antibiotics. Furthermore, the treatment of
this infection has a minimum duration of six months, and the early improvement of
symptoms often leads to its interruption, favoring the emergence of drug-resistant
strains. This scenario highlights the need to search for new therapeutic alternatives. In
this context, silver(I) compounds have attracted attention due to their antimicrobial
properties and the non-specific mechanism of action of the metal ion, which reduces
the likelihood of resistance development. The coordination of silver(I) with sulfadiazine,
a widely known antimicrobial agent, and with triphenylphosphine, which is capable of
increasing the lipophilicity of the complex, represents a promising strategy for obtaining
compounds with potential biological activity. Thus, this study aimed to synthesize and
characterize new silver(I) complexes containing sulfadiazine and triphenylphosphine
in different ratios (1:1:1 and 1:1:2). Characterizations were performed by elemental
analysis, thermal analysis (TG/DTA), vibrational spectroscopy in the infrared region
and Raman spectroscopy, nuclear magnetic resonance spectroscopy (1H, 13C, and
31P), as well as heteronuclear correlation HMBC {15N,1H}, and single-crystal X-ray
diffraction. The obtained results confirmed the formation of the complexes, allowed the
evaluation of their thermal stability, and enabled the elucidation of their structures.
Furthermore, future studies are intended to evaluate the biological properties of these
compounds, particularly their potential as candidates for the development of new
antituberculosis agents.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

